These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B, Crawford F, Bachmeier C. Fluids Barriers CNS; 2016 Aug 08; 13(1):14. PubMed ID: 27503326 [Abstract] [Full Text] [Related]
4. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition. Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G. J Neurosci; 2017 Apr 12; 37(15):4023-4031. PubMed ID: 28275161 [Abstract] [Full Text] [Related]
5. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model. Kim SH, Ahn JH, Yang H, Lee P, Koh GY, Jeong Y. Acta Neuropathol Commun; 2020 Nov 05; 8(1):181. PubMed ID: 33153499 [Abstract] [Full Text] [Related]
6. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. Kanekiyo T, Zhang J, Liu Q, Liu CC, Zhang L, Bu G. J Neurosci; 2011 Feb 02; 31(5):1644-51. PubMed ID: 21289173 [Abstract] [Full Text] [Related]
7. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, Verghese PB, Herz J, Holtzman DM, Zlokovic BV. Mol Neurodegener; 2018 Oct 19; 13(1):57. PubMed ID: 30340601 [Abstract] [Full Text] [Related]
8. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Haglund M, Kalaria R, Slade JY, Englund E. Acta Neuropathol; 2006 May 19; 111(5):430-5. PubMed ID: 16555084 [Abstract] [Full Text] [Related]
9. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy. Clifford PM, Siu G, Kosciuk M, Levin EC, Venkataraman V, D'Andrea MR, Nagele RG. Brain Res; 2008 Oct 09; 1234():158-71. PubMed ID: 18708033 [Abstract] [Full Text] [Related]
10. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, Deane RJ, Zhong E, Parisi M, Ciszewski J, Kasper RT, Deane R. Proc Natl Acad Sci U S A; 2013 Sep 03; 110(36):14771-6. PubMed ID: 23959870 [Abstract] [Full Text] [Related]
11. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus. P X, Zz L, Gg J, Lp W, Cm B, Yl W, Chen MF, W L. Neurochem Int; 2022 Nov 03; 160():105417. PubMed ID: 36067928 [Abstract] [Full Text] [Related]
12. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease. Alemi M, Silva SC, Santana I, Cardoso I. CNS Neurosci Ther; 2017 Jul 03; 23(7):605-619. PubMed ID: 28570028 [Abstract] [Full Text] [Related]
14. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM. Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J, Pietrzik CU. Brain Behav Immun; 2018 Oct 03; 73():21-33. PubMed ID: 30041013 [Abstract] [Full Text] [Related]
15. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice. Button EB, Boyce GK, Wilkinson A, Stukas S, Hayat A, Fan J, Wadsworth BJ, Robert J, Martens KM, Wellington CL. Alzheimers Res Ther; 2019 May 13; 11(1):44. PubMed ID: 31084613 [Abstract] [Full Text] [Related]
16. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain. Sagare AP, Bell RD, Srivastava A, Sengillo JD, Singh I, Nishida Y, Chow N, Zlokovic BV. J Biol Chem; 2013 May 24; 288(21):15154-66. PubMed ID: 23580652 [Abstract] [Full Text] [Related]
17. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. Rolyan H, Feike AC, Upadhaya AR, Waha A, Van Dooren T, Haass C, Birkenmeier G, Pietrzik CU, Van Leuven F, Thal DR. J Neural Transm (Vienna); 2011 May 24; 118(5):699-712. PubMed ID: 21210284 [Abstract] [Full Text] [Related]
18. Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake. Kanekiyo T, Bu G. J Biol Chem; 2009 Nov 27; 284(48):33352-9. PubMed ID: 19826010 [Abstract] [Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport. Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX. Neuroscience; 2016 May 13; 322():28-38. PubMed ID: 26820600 [Abstract] [Full Text] [Related]
20. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow. Li H, Guo Q, Inoue T, Polito VA, Tabuchi K, Hammer RE, Pautler RG, Taffet GE, Zheng H. Mol Neurodegener; 2014 Aug 09; 9():28. PubMed ID: 25108425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]